Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 522664-63-7
2. Men-15596
3. Ibodutant [inn]
4. Men15596
5. 1h7rsq28bj
6. 6-methyl-n-[1-[[(2r)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide
7. Men 15596
8. Unii-1h7rsq28bj
9. (r)-6-methyl-n-(1-((1-oxo-3-phenyl-1-(((1-((tetrahydro-2h-pyran-4-yl)methyl)piperidin-4-yl)methyl)amino)propan-2-yl)carbamoyl)cyclopentyl)benzo[b]thiophene-2-carboxamide
10. Ibodutant [who-dd]
11. Schembl464393
12. Chembl266125
13. Gtpl2117
14. C37h48n4o4s
15. Dtxsid20966639
16. Bdbm50476750
17. Db12042
18. 6-methylbenzo(b)thiophene-2-carboxylic Acid (1-(2-phenyl-((1-(tetrahydropyran-4-ylmethyl)piperidin-4-ylmethyl)carbamoyl)ethylcarbamoyl)cyclophenyl)amide
19. Hy-14770
20. Cs-0003551
21. Q5984345
22. 6-methyl-n-(1-(((2r)-1-((1-(oxan-4-ylmethyl)piperidin-4- Yl)methylamino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)cyclopentyl)-1-benzothiophene-2-carboxamide
23. Benzo(b)thiophene-2-carboxamide, 6-methyl-n-(1-((((1r)-2-oxo-1-(phenylmethyl)-2-(((1-((tetrahydro-2h-pyran-4-yl)methyl)-4-piperidinyl)methyl)amino)ethyl)amino)carbonyl)cyclopentyl)-
| Molecular Weight | 644.9 g/mol |
|---|---|
| Molecular Formula | C37H48N4O4S |
| XLogP3 | 6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 11 |
| Exact Mass | 644.33962720 g/mol |
| Monoisotopic Mass | 644.33962720 g/mol |
| Topological Polar Surface Area | 128 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of diarrhoea-predominant irritable bowel Syndrome
ABOUT THIS PAGE
57
PharmaCompass offers a list of Ibodutant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibodutant manufacturer or Ibodutant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibodutant manufacturer or Ibodutant supplier.
PharmaCompass also assists you with knowing the Ibodutant API Price utilized in the formulation of products. Ibodutant API Price is not always fixed or binding as the Ibodutant Price is obtained through a variety of data sources. The Ibodutant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ibodutant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibodutant, including repackagers and relabelers. The FDA regulates Ibodutant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibodutant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ibodutant supplier is an individual or a company that provides Ibodutant active pharmaceutical ingredient (API) or Ibodutant finished formulations upon request. The Ibodutant suppliers may include Ibodutant API manufacturers, exporters, distributors and traders.
Ibodutant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ibodutant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ibodutant GMP manufacturer or Ibodutant GMP API supplier for your needs.
A Ibodutant CoA (Certificate of Analysis) is a formal document that attests to Ibodutant's compliance with Ibodutant specifications and serves as a tool for batch-level quality control.
Ibodutant CoA mostly includes findings from lab analyses of a specific batch. For each Ibodutant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ibodutant may be tested according to a variety of international standards, such as European Pharmacopoeia (Ibodutant EP), Ibodutant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ibodutant USP).
